Books > Science & Mathematics > Biology, life sciences > Life sciences: general issues > Neurosciences
|
Buy Now
Excitotoxicity in Neurological Diseases - New Therapeutic Challenge (Paperback, Softcover reprint of the original 1st ed. 2004)
Loot Price: R4,363
Discovery Miles 43 630
|
|
Excitotoxicity in Neurological Diseases - New Therapeutic Challenge (Paperback, Softcover reprint of the original 1st ed. 2004)
Expected to ship within 10 - 15 working days
|
It can be reasonably anticipated that, over the next generations,
the proportion of elderly people will remarkably increase and, with
this, the number ofpersons suffering from acute (e.g. cerebral
ischemia) or chronic neurodegenerative disorders. To date, approved
drugs only alleviate the symptoms ofthese diseases (for instance,
acetylcholinesterase inhibitors in Alzheimer disease and L-dopa and
dopamine-agonists in Parkinson disease), while none seems to stop
the progression of the degenerative processes underlying them. The
development of effective preventive or protective therapies has
been impeded by the limitations of our knowledge of the causes and
the mechanisms by which neurons die in neurodegenerative disorders.
Evidence accumulated in the past 20 years indicated that the major
excitatory neurotransmitter glutamate may play a role as neurotoxin
in several conditions. In particular, the glutamatergic system
dysfunction seems to be an early event working as a common pathway
in the pathogenesis ofa large number ofacute and chronic
neurological disorders, in strict conjunction with other important
mechanisms, such as oxidative stress and energetic failure, and
probably triggered by different mechanisms in various diseases. In
consideration of that, drug discovery efforts over the last decade
have been focused on the search for drugs that either reduce
glutamate synaptic levels or block its postsynaptic effects.
Despite numerous reviews on basic mechanisms and clinical aspects
ofthe excitotoxic phenomenon, so far no comprehensive book has
covered the topic in all its complexity, starting from basic
pharmacological mechanisms, to .animal models of diseases and
finally to clinical pathogenic and therapeutic implications.
General
Is the information for this product incomplete, wrong or inappropriate?
Let us know about it.
Does this product have an incorrect or missing image?
Send us a new image.
Is this product missing categories?
Add more categories.
Review This Product
No reviews yet - be the first to create one!
|
|
Email address subscribed successfully.
A activation email has been sent to you.
Please click the link in that email to activate your subscription.